The report, published Thursday in the medical journal JAMA Ophthalmology, found that five out of 25,330 patients studied, or less than 0.02%, of those who took Ozempic and Wegovy, also known as GLP-1 drugs, developed non-arteritic anterior ischemic optic neuropathy, or NAION, a sudden loss of vision in one eye
Narration: And I found myself around 320 pounds and tried a lot of different diets, and I got myself down to about 215 pounds
High-yield reporting fields for suspected semaglutide-related vaginal symptoms include: dose and escalation dates, concomitant SGLT2 inhibitor use, antibiotic/antifungal use, menopausal status/HRT, diabetes control markers, symptom description with onset/offset, objective test results (pH, microscopy/NAAT), and dechallenge/rechallenge outcomes if they occur
Switching medications The effect of GLP-1 medications varies from person to person
Magnesium: Many users swear by magnesium supplements at night
10.3389/fendo.2018.00314 146 SacksD.BaxterB.CampbellB